< Back to Article

Rational discovery of dual-indication multi-target PDE/Kinase inhibitor for precision anti-cancer therapy using structural systems pharmacology

Table 3

Overrepresented GO biological process terms responsible for the anti-cancer sensitivity of levosimendan.

doi: https://doi.org/10.1371/journal.pcbi.1006619.t003